68 related articles for article (PubMed ID: 36610660)
1. Development of IL-17A inhibitor-induced atopic dermatitis-like rash in psoriasis patients: Insights into immune shift.
Li Q; Li X; Li W; Fan R; Ma Q; Luo X; Jian H; Chen X; Cao C; Zheng W
Exp Dermatol; 2024 Jan; 33(1):e14958. PubMed ID: 38009235
[TBL] [Abstract][Full Text] [Related]
2. A pediatric case of dupilumab-induced pustular psoriasis.
Dang N; Zheng H; Ren Y
J Dermatolog Treat; 2024 Dec; 35(1):2333016. PubMed ID: 38839072
[TBL] [Abstract][Full Text] [Related]
3. Concurrence of psoriasis vulgaris and atopic eczema in a single patient exhibiting different expression patterns of psoriatic autoantigens in the lesional skin.
Ono S; Honda T; Doi H; Kabashima K
JAAD Case Rep; 2018 Jun; 4(5):429-433. PubMed ID: 29984272
[No Abstract] [Full Text] [Related]
4. Genomic Profiling of the Overlap Phenotype between Psoriasis and Atopic Dermatitis.
Kim JE; Lee J; Huh YJ; Kim K; Chaparala V; Krueger JG; Kim J
J Invest Dermatol; 2024 Jan; 144(1):43-52.e6. PubMed ID: 37419444
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical psoriasis induced by IL-17 inhibitors: a case series of patients with axial spondyloarthritis and a systematic literature review.
Chaitidis N; Papadopoulou Z; Varvara ST; Panagiotidis M; Katsigianni I; Sakellariou GT
Rheumatol Int; 2024 Jun; ():. PubMed ID: 38914777
[TBL] [Abstract][Full Text] [Related]
6. Targeted review of
Krueger JG; Pagotto A; Haftel S; Gradl B
Skin Health Dis; 2024 Apr; 4(2):e343. PubMed ID: 38577038
[TBL] [Abstract][Full Text] [Related]
7. A case of dupilumab-induced psoriasis-like eruption treated with baricitinib.
Kinoshita Y; Imanishi H; Oshimo T; Tsuruta D
Skin Health Dis; 2024 Apr; 4(2):e338. PubMed ID: 38577056
[TBL] [Abstract][Full Text] [Related]
8. Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition.
Dong S; Li D; Shi D
Front Med (Lausanne); 2024; 11():1335551. PubMed ID: 38606161
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry-Based Proteomics Analysis Unveils PTPRS Inhibits Proliferation and Inflammatory Response of Keratinocytes in Psoriasis.
Zheng X; Zhou C; Hu Y; Xu S; Hu L; Li B; Zhao X; Li Q; Tang X; Huang K
Inflammation; 2024 May; ():. PubMed ID: 38739342
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Single T-Cell Transcriptomic Discrimination of Atopic Dermatitis Versus Psoriasis Vulgaris.
Taylor MA; El Kurdi A; Hailer A; Wang S; Yuan M; Mukhopadhyay S; Bhutani T; North JP; Cho RJ; Cheng JB
J Invest Dermatol; 2024 Apr; 144(4):898-901.e3. PubMed ID: 37879399
[No Abstract] [Full Text] [Related]
11. Manually curated and harmonised transcriptomics datasets of psoriasis and atopic dermatitis patients.
Federico A; Hautanen V; Christian N; Kremer A; Serra A; Greco D
Sci Data; 2020 Oct; 7(1):343. PubMed ID: 33051456
[TBL] [Abstract][Full Text] [Related]
12. Aberrations in Lipid Expression and Metabolism in Psoriasis.
Nowowiejska J; Baran A; Flisiak I
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207318
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical psoriasis induced by IL-17 antagonists.
Wang Y; Yang F; Wang R; Luo S
Indian J Dermatol Venereol Leprol; 2024 Apr; ():1-9. PubMed ID: 38594973
[TBL] [Abstract][Full Text] [Related]
14. Improving systemic therapy selection for inflammatory skin diseases: A clinical need survey.
Brownstone ND; Farberg AS; Litchman GH; Quick AP; Siegel JJ; Hurton LV; Goldberg MS; Lio PA
JAAD Int; 2024 Sep; 16():49-56. PubMed ID: 38774343
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis pathogenesis - Pso p27 constitutes a compact structure forming large aggregates.
Lysvand H; Helland R; Hagen L; Slupphaug G; Iversen OJ
Biochem Biophys Rep; 2015 Jul; 2():132-136. PubMed ID: 29124154
[TBL] [Abstract][Full Text] [Related]
16. Newly Discovered Corneodesmosin Defects in Generalized Pustular Psoriasis.
Simon M
J Invest Dermatol; 2024 Apr; 144(4):731-733. PubMed ID: 38300198
[No Abstract] [Full Text] [Related]
17. Dupilumab-Induced Follicular Psoriasis and Hypercytokinemia.
Jiao Y; Li L; Zhao A; Wang M; Liu T; Wang X; Liu Y; Sun Y
Dermatitis; 2024 Mar; ():. PubMed ID: 38498050
[No Abstract] [Full Text] [Related]
18. "De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature.
Trave I; Salvi I; Burlando M; Cozzani E; Parodi A
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834935
[TBL] [Abstract][Full Text] [Related]
19. IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis.
Grolleau C; Calugareanu A; Demouche S; Nosbaum A; Staumont-Sallé D; Aubert H; Cassius C; Jachiet M; Saussine A; Bagot M; Bachelez H; Battistella M; Hotz C; Du Thanh A; Crépy MN; Bergerat D; Merandet M; Onifarasoaniaina R; Alberdi A; How-Kit A; Bouaziz JD; Le-Buanec H
J Invest Dermatol; 2023 May; 143(5):711-721.e7. PubMed ID: 36610660
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
